227 related articles for article (PubMed ID: 24651058)
1. Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.
Sonmez O; Ertem FU; Vatankulu MA; Erdogan E; Tasal A; Kucukbuzcu S; Goktekin O
Med Sci Monit; 2014 Mar; 20():463-70. PubMed ID: 24651058
[TBL] [Abstract][Full Text] [Related]
2. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome.
Ionin VA; Baranova EI; Zaslavskaya EL; Petrishcheva EY; Morozov AN; Shlyakhto EV
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784491
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.
Zhao L; Li S; Zhang C; Tian J; Lu A; Bai R; An J; Greiser A; Huang J; Ma X
J Cardiovasc Magn Reson; 2021 Mar; 23(1):30. PubMed ID: 33745456
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.
Zhao F; Zhang S; Chen Y; Gu W; Ni B; Shao Y; Wu Y; Qin J
BMC Cardiovasc Disord; 2014 Nov; 14():167. PubMed ID: 25422138
[TBL] [Abstract][Full Text] [Related]
6. Associations Between Neutrophil Gelatinase Associated Lipocalin, Neutrophil-to-Lymphocyte Ratio, Atrial Fibrillation and Renal Dysfunction in Chronic Heart Failure.
Argan O; Ural D; Kozdag G; Sahin T; Bozyel S; Aktas M; Karauzum K; Yilmaz I; Dervis E; Agir A
Med Sci Monit; 2016 Dec; 22():4765-4772. PubMed ID: 27918494
[TBL] [Abstract][Full Text] [Related]
7. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?
Yigit IP; Celiker H; Dogukan A; Ilhan N; Gurel A; Ulu R; Aygen B
Ren Fail; 2015 Feb; 37(1):77-82. PubMed ID: 25347233
[TBL] [Abstract][Full Text] [Related]
8. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation.
Swartz MF; Fink GW; Sarwar MF; Hicks GL; Yu Y; Hu R; Lutz CJ; Taffet SM; Jalife J
J Am Coll Cardiol; 2012 Oct; 60(18):1799-806. PubMed ID: 23040566
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation.
Sasaki N; Okumura Y; Watanabe I; Mano H; Nagashima K; Sonoda K; Kogawa R; Ohkubo K; Nakai T; Hirayama A
J Interv Card Electrophysiol; 2014 Apr; 39(3):241-9. PubMed ID: 24554250
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive assessment of left atrial fibrosis. Correlation between echocardiography, biomarkers, and electroanatomical mapping.
Pilichowska-Paszkiet E; Baran J; Sygitowicz G; Sikorska A; Stec S; Kułakowski P; Zaborska B
Echocardiography; 2018 Sep; 35(9):1326-1334. PubMed ID: 29900593
[TBL] [Abstract][Full Text] [Related]
11. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
12. Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome.
Richter B; Gwechenberger M; Socas A; Zorn G; Albinni S; Marx M; Wolf F; Bergler-Klein J; Loewe C; Bieglmayer C; Binder T; Wojta J; Gössinger HD
Int J Cardiol; 2011 Oct; 152(2):231-6. PubMed ID: 20692054
[TBL] [Abstract][Full Text] [Related]
13. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
[TBL] [Abstract][Full Text] [Related]
14. Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Heckbert SR; Alonso A; Gross MD; Ix JH; Kizer JR; Tracy RP; Kronmal R; Jacobs DR
Circ Arrhythm Electrophysiol; 2018 Oct; 11(10):e006557. PubMed ID: 30354407
[TBL] [Abstract][Full Text] [Related]
15. Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion.
Kawamura M; Munetsugu Y; Kawasaki S; Onishi K; Onuma Y; Kikuchi M; Tanno K; Kobayashi Y
Europace; 2012 Dec; 14(12):1719-25. PubMed ID: 22622138
[TBL] [Abstract][Full Text] [Related]
16. Association between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation.
Müller P; Maier J; Dietrich JW; Barth S; Griese DP; Schiedat F; Szöllösi A; Halbfass P; Nentwich K; Roos M; Krug J; Schade A; Schmitt R; Mügge A; Deneke T
J Interv Card Electrophysiol; 2015 Oct; 44(1):55-62. PubMed ID: 26048130
[TBL] [Abstract][Full Text] [Related]
17. MMP-9 in atrial remodeling in patients with atrial fibrillation.
Lewkowicz J; Knapp M; Tankiewicz-Kwedlo A; Sawicki R; Kamińska M; Waszkiewicz E; Musiał WJ
Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):285-91. PubMed ID: 25869465
[TBL] [Abstract][Full Text] [Related]
18. High sensitive C-reactive protein and interleukin 6 in atrial fibrillation with rheumatic mitral stenosis from Indian cohort.
Sharma G; Shetkar S; Bhasin A; Ramakrishnan L; Juneja R; Naik N; Roy A; Ramakrishnan S; Bhargava B; Bahl VK
Indian Heart J; 2017; 69(4):505-511. PubMed ID: 28822519
[TBL] [Abstract][Full Text] [Related]
19. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation.
Begg GA; Swoboda PP; Karim R; Oesterlein T; Rhode K; Holden AV; Greenwood JP; Shantsila E; Lip GYH; Plein S; Tayebjee MH
J Cardiovasc Magn Reson; 2020 Feb; 22(1):13. PubMed ID: 32036784
[TBL] [Abstract][Full Text] [Related]
20. Correlation between circulating fibrosis biomarkers with left atrial function and left atrial volume index in rheumatic mitral stenosis.
Asrial AA; Reviono R; Soetrisno S; Setianto BY; Widyaningsih V; Nurwati I; Wasita B; Pudjiastuti A
Narra J; 2024 Apr; 4(1):e293. PubMed ID: 38798862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
